PharmaNutrients, Inc. – Trademark Portfolio
Entity Type: 03
PharmaNutrients, Inc. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 26 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PHARMANUTRIENTS, INC.. The owner is based in Gurnee, IL.
1519 St. Paul Avenue
Gurnee, IL 60031
Showing of trademarks Trademarks
Trademark Classifications
PharmaNutrients, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does PharmaNutrients, Inc. have?
PharmaNutrients, Inc. has 28 U.S. trademarks filed with the USPTO. Of these, 1 registered, 19 abandoned, 8 cancelled.
What trademark classes does PharmaNutrients, Inc. file in?
PharmaNutrients, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PharmaNutrients, Inc.'s most well-known trademarks?
PharmaNutrients, Inc.'s registered trademark portfolio includes well-known marks such as PHARMANUTRIENTS, INC.. These are among 1 currently registered trademark in the portfolio.
What is PharmaNutrients, Inc.'s trademark registration success rate?
PharmaNutrients, Inc. has a 4% trademark registration rate, with 1 out of 28 resolved applications resulting in successful registration. Currently, 0 applications are pending review.